FADD gene therapy for malignant gliomas in vitro and in vivo

Human Gene Therapy

Volumn 9, Issue 11, 1998, Pages 1599-1608

  Kondo, Seiji ^a   Ishizaka, Yukihito ^b   Okada, Takashi ^c   Kondo, Yasuko ^a   Hitomi, Masahiro ^a   Tanaka, Yoshikazu ^d   Haqqi, Talat ^a   Barnett, Gene H ^a   Barna, Barbara P ^e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN; RECEPTOR ANTIBODY;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; RETROVIRUS;

UNIDENTIFIED RETROVIRUS;

EID: 0032551590     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.11-1599     Document Type: Article

References (10)

1. ANDERSEN, J.K., GARBER, D.A., MEANEY, C.A., BREAKEFIELD, X.O. (1992). Gene transfer into the mammalian central nervous system using herpes virus vectors: Extended expression of the bacterial lacZ in neurons using the neuron-specific enolase promoter. Hum. Gene Ther. 3, 487-199.
2. BAKER, S.J., and REDDY, E.P. (1996). Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9.
3. BOISE, L.H., GONZALEZ-GARCIA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NUNEZ, G., and THOMPSON, C.B. (1993). bcl-X, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
4. BOLDIN, M.P., VARFOLOMEEV, E.E., PANCER, Z., METT, I.L., CAMONIS, J.H., and WALLACH, D. (1995). A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
5. CHINNAIYAN, A.M., O'ROURKE, K., TEWARI, M., and DIXIT, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
6. CHINNAIYAN, A.M., TEPPER, C.G., SELDIN, M.F., O'ROURKE, K., KISCHKEL, F.C., HELLBARDT, S., KRAMMER, P.H., PETER, M.E., and DIXIT, V.M. (1996). FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965.
7. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
8. DEEN, F.D., CHIARADO, A., GRIMM, E.A., FIKE, J.R., ISRAEL, M.A., KUN, L.E., LEVIN, V.A., MARTON, L.J., PACKER, R.J., PEGG, A.E., ROSENBLUM, M.L., SUIT, H.D., WALKER, M.D., WIKSTRAND, C.J., WILSON, C.B., WONG, A.J., and YUNG, W.K.A. (1993). Brain tumor working group report on the 9th International Conference on Brain Tumor Research and Therapy. J. Neuro-Oncol. 16, 243-272.
9. DHEIN, J., DANIEL, P.T., TRAUTH, B.C., OEHM, A., MOLLER, P., and KRAMMER, P.H. (1992). Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149, 3166-3173.
10. WELLER, M., FREI, K., GROSCURTH, P., KRAMMER, P.H., YONEKAWA, Y., and FONTANA, A. (1994). Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells, induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94, 954-964.